Q2 2021 Holdings
Filed 2021-08-13 | 195 holdings | $6.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $2.1M | 164,840 | 35.8% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $1.4M | 99,655 | 23.1% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $901.0K | 8,000 | 15.1% |
| Butterfly Network, Inc.(BFLY) | Common | 124155102 | $663.0K | 45,760 | 11.1% |
| Corteva Inc.(CTVA) | Common | 22052L104 | $490.0K | 12,033 | 8.2% |
| Cousins Properties(CUZ) | Common | 222795502 | $123.0K | 3,357 | 2.1% |
| Calumet Specialty Products Partners, LP | Common | 131476103 | $21.7K | 3,153,300 | 0.4% |
| Apollo Global Management, Inc.(APOEUR) | Common | 03768E105 | $18.7K | 300,000 | 0.3% |
| Fortress Trans & Infrastructure Inv. LLC | Common | 34960P101 | $16.7K | 497,700 | 0.3% |
| Coliseum Acquisition Corp. | Common | G2263T115 | $14.7K | 1,485,000 | 0.2% |
| Alphabet Inc(GOOG) | Common | 02079K107 | $14.0K | 5,600 | 0.2% |
| Upland Software, Inc.(UPLD) | Common | 91544A109 | $12.4K | 300,000 | 0.2% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $9.8K | 75,000 | 0.2% |
| FS KKR Capital Corp.(FSK) | Common | 302635206 | $8.5K | 395,175 | 0.1% |
| Midwest Holding Inc. | Common | 59833J206 | $6.5K | 165,000 | 0.1% |
| Pershing Square Holdings, Ltd | Common | 71531R109 | $6.3K | 275,000 | 0.1% |
| KKR & Co. Inc.(KKR) | Common | 48251W104 | $5.9K | 100,000 | 0.1% |
| African Gold Acquistion Corp. Warrants | Common | G0112R124 | $5.3K | 463,500 | 0.1% |
| Support.com, Inc.Put | Common | 86858W200 | $5.3K | 1,361,900 | 0.1% |
| B. Riley Principal 150 Merger Corp. | Common | 05601V103 | $5.2K | 526,963 | 0.1% |
| Danimer Scientific, Inc. | Common | 236272100 | $5.0K | 200,000 | 0.1% |
| Twelve Seas Investment Company II | Common | 90118T106 | $5.0K | 515,000 | 0.1% |
| Glass Houses Acquisition Corp. | Common | 37714P103 | $4.8K | 500,000 | 0.1% |
| Pfizer Inc.(PFE) | Common | 717081103 | $4.7K | 119,900 | 0.1% |
| Kennedy-Wilson Holdings, Inc.(KW) | Common | 489398107 | $4.2K | 210,000 | 0.1% |
| Eastern Bankshares Inc(EBC) | Common | 27627N105 | $4.1K | 200,000 | 0.1% |
| Live Oak Mobility Aquisition Corp. | Common | 538126103 | $3.5K | 360,152 | 0.1% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $3.4K | 6,000 | 0.1% |
| Kairos Acquisition Corp. | Common | G52110114 | $3.4K | 345,463 | 0.1% |
| Kadmon Holdings, Inc.(KDMN) | Common | 48283N106 | $3.2K | 838,190 | 0.1% |
| Constellation Pharmaceuticals, Inc.(CNST) | Common | 210373106 | $3.1K | 91,909 | 0.1% |
| Horizon Therapeutics Public Ltd. Company | Common | G46188101 | $3.0K | 32,000 | 0.1% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $2.9K | 43,409 | 0.0% |
| Glass Houses Acquisition Corp. Warrants | Common | 37714P111 | $2.9K | 250,000 | 0.0% |
| JP Morgan Chase(JPM) | Common | 46625H100 | $2.8K | 18,170 | 0.0% |
| United Therapeutics Corporation(UTHR) | Common | 91307C102 | $2.7K | 15,300 | 0.0% |
| Xenon Pharmaceuticals Inc.(XENE) | Common | 98420N105 | $2.6K | 140,551 | 0.0% |
| International Gaming Technologies(BRSL) | Common | G4863A108 | $2.6K | 107,500 | 0.0% |
| Eiger BioPharmaceuticals, Inc.(CLDNEUR) | Common | 28249U105 | $2.4K | 286,554 | 0.0% |
| AllianceBernstein Holdings PL Unit Ltd(AB) | Common | 01881G106 | $2.4K | 50,500 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $2.2K | 124,688 | 0.0% |
| Horizon Acquistion Corporation | Common | G46044106 | $2.1K | 210,100 | 0.0% |
| Avadel Pharmaceuticals plc | Common | 05337M104 | $2.1K | 304,922 | 0.0% |
| Twelve Seas Investment Company II Warrants | Common | 90118T114 | $2.0K | 171,666 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | Common | 88322Q108 | $2.0K | 50,373 | 0.0% |
| Tastemaker Acquisition Corp. | Common | 876545104 | $1.9K | 200,000 | 0.0% |
| Medicus Science Acquisition, Corp. | Common | G59605108 | $1.9K | 200,000 | 0.0% |
| Trillium Therapeutics Inc. | Common | 89620X506 | $1.9K | 198,699 | 0.0% |
| Kairos Acquisition Corp. Warrants | Common | G52110106 | $1.7K | 146,528 | 0.0% |
| Aslan Pharmaceuticals Limited | Common | 04522R101 | $1.6K | 478,186 | 0.0% |